Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Rupal Desai"'
Autor:
Monika A Jarzabek, William R Proctor, Jennifer Vogt, Rupal Desai, Patrick Dicker, Gary Cain, Rajiv Raja, Jens Brodbeck, Dale Stevens, Eric P van der Stok, John W M Martens, Cornelis Verhoef, Priti S Hegde, Annette T Byrne, Jacqueline M Tarrant
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198099 (2018)
Drug-related sinusoidal dilatation (SD) is a common form of hepatotoxicity associated with oxaliplatin-based chemotherapy used prior to resection of colorectal liver metastases (CRLM). Recently, hepatic SD has also been associated with anti-delta lik
Externí odkaz:
https://doaj.org/article/fe0051c7ad654064b4d0da667c7b0515
Autor:
Erica B Schleifman, Rachel Tam, Rajesh Patel, Alison Tsan, Teiko Sumiyoshi, Ling Fu, Rupal Desai, Nancy Schoenbrunner, Thomas W Myers, Keith Bauer, Edward Smith, Rajiv Raja
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90761 (2014)
Molecular profiling of tumor tissue to detect alterations, such as oncogenic mutations, plays a vital role in determining treatment options in oncology. Hence, there is an increasing need for a robust and high-throughput technology to detect oncogeni
Externí odkaz:
https://doaj.org/article/d1158b5fc13d4e72b1efa7d3f70cf372
Autor:
Erica B Schleifman, Rupal Desai, Jill M Spoerke, Yuanyuan Xiao, Cheryl Wong, Ilma Abbas, Carol O'Brien, Rajesh Patel, Teiko Sumiyoshi, Ling Fu, Rachel N Tam, Hartmut Koeppen, Timothy R Wilson, Rajiv Raja, Garret M Hampton, Mark R Lackner
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88401 (2014)
Patients with newly diagnosed, early stage estrogen receptor positive (ER+) breast cancer often show disease free survival in excess of five years following surgery and systemic adjuvant therapy. An important question is whether diagnostic tumor tiss
Externí odkaz:
https://doaj.org/article/9d35a2ef4deb49188851b092086a7efd
Autor:
Rajesh Patel, Alison Tsan, Rachel Tam, Rupal Desai, Jill Spoerke, Nancy Schoenbrunner, Thomas W. Myers, Keith Bauer, Edward Smith, Rajiv Raja
Publikováno v:
PLoS ONE, Vol 8, Iss 9 (2013)
Externí odkaz:
https://doaj.org/article/fc7e5e0a97114cf0bb1e2d137999556b
Autor:
Rajesh Patel, Alison Tsan, Rachel Tam, Rupal Desai, Jill Spoerke, Nancy Schoenbrunner, Thomas W Myers, Keith Bauer, Edward Smith, Rajiv Raja
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51153 (2012)
Targeted anticancer therapies rely on the identification of patient subgroups most likely to respond to treatment. Predictive biomarkers play a key role in patient selection, while diagnostic and prognostic biomarkers expand our understanding of tumo
Externí odkaz:
https://doaj.org/article/c769aec52df6435e801952ca04055afa
Autor:
Geoffrey J. Lindeman, Tharu M. Fernando, Rebecca Bowen, Katarzyna J. Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steve McCune, Anne Armstrong, Catherine Shannon, Gianfilippo Bertelli, Ching-Wei Chang, Rupal Desai, Kushagra Gupta, Timothy R. Wilson, Aulde Flechais, Aditya Bardia
Publikováno v:
Clinical Cancer Research. 28:3256-3267
Purpose: Despite promising activity in hematopoietic malignancies, efficacy of the B-cell lymphoma 2 (BCL2) inhibitor venetoclax in solid tumors is unknown. We report the prespecified VERONICA primary results, a randomized phase II clinical trial eva
Autor:
Ron Firestein, Paul Polakis, Peter M. Haverty, Brad A. Friedman, Rajiv Raja, Rupal Desai, Karen Gascoigne, Elizabeth Luis, Sreedevi Chalasani, Susan Spencer, Josh Tanguay, Chie Sakanaka, Peter Chang, Jarrod Tremayne, Lisa Crocker, Jyoti Asundi
Supplemental Methods and Figure Legends. Supplementary methods to the article as well as figure legends to the supplementary figures and supplementary tables are provided.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ad7ff23a61c7edab0ff422507f15f2
https://doi.org/10.1158/1078-0432.22459758.v1
https://doi.org/10.1158/1078-0432.22459758.v1
Autor:
Robert L. Yauch, Amy Peterson, Premal Patel, See-Chun Phan, Lukas Amler, Vanitha Ramakrishnan, Mirella Lazarov, Jenny Huang, Marina Lipkind, Ignacio Wistuba, David S. Shames, Ellen Filvaroff, Sharianne G. Louie, Tom Januario, Xiaoling Xia, Vaishali Parab, An Do, Ling Fu, Rupal Desai, Rajesh Patel, Sankar Mohan, Rajiv Raja, Linda Rangell, Elicia Penuel, Ajay Pandita, Jiping Zha, Wei Yu, Hartmut Koeppen
Figure S1. Characterization of SP44 specificity; Figure S2. Relationship of IHC intensity with FACS; Figure S3. Relationship of IHC intensity with mRNA; Figure S4. Representative IHC images; Figure S5 and S6. MET IHC H-scores; Figure S7. Relationship
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f30d3401a7f695ff0b6715b48881b37
https://doi.org/10.1158/1078-0432.22447172
https://doi.org/10.1158/1078-0432.22447172
Autor:
Aditya Bardia, Aulde Flechais, Timothy R. Wilson, Kushagra Gupta, Rupal Desai, Ching-Wei Chang, Gianfilippo Bertelli, Catherine Shannon, Anne Armstrong, Steve McCune, Frances Boyle, Thomas Decker, Xinni Song, Katarzyna J. Jerzak, Rebecca Bowen, Tharu M. Fernando, Geoffrey J. Lindeman
Supplementary Data from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003d9ac655eca985a9fe7e9508e49303
https://doi.org/10.1158/1078-0432.22487561.v1
https://doi.org/10.1158/1078-0432.22487561.v1
Autor:
Ron Firestein, Paul Polakis, Peter M. Haverty, Brad A. Friedman, Rajiv Raja, Rupal Desai, Karen Gascoigne, Elizabeth Luis, Sreedevi Chalasani, Susan Spencer, Josh Tanguay, Chie Sakanaka, Peter Chang, Jarrod Tremayne, Lisa Crocker, Jyoti Asundi
Purpose: Chemotherapies are limited by a narrow therapeutic index resulting in suboptimal exposure of the tumor to the drug and acquired tumor resistance. One approach to overcome this is through antibody–drug conjugates (ADC) that facilitate great
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5b70fe25acb3da63c0553544fd0cae
https://doi.org/10.1158/1078-0432.c.6524301
https://doi.org/10.1158/1078-0432.c.6524301